Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants is a research paper published in Advanced Therapeutics (2021). On theSindex it has a DataRank of 1.3. It has been cited 44 times, with 37 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0.764
From 34 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 37 citers.
National Institutes of Health
Grant: RF1AG059723
National Institutes of Health
Grant: R35GM136300
National Institutes of Health
Grant: F32 GM137513
National Institutes of Health
Grant: R01 AI 51588
National Science Foundation
Grant: CBET 1159943
National Science Foundation
Grant: 1605266
National Science Foundation
Grant: 1813963
Michigan Institute for Clinical and Health Research
Grant: University of Michigan MICHR Accelerating Synergy Award
NIAID NIH HHS
Grant: R01 AI048602
NIAID NIH HHS
Grant: R01 AI051588
NIAID NIH HHS
Grant: R01 AI151588
FWCI
2.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals